Literature DB >> 12421101

Chronic fatigue syndrome: probable pathogenesis and possible treatments.

Birgitta Evengård1, Nancy Klimas.   

Abstract

Chronic fatigue syndrome (CFS) belongs in the medically unexplained illnesses. It affects approximately 0.2-0.7% of the population in Western countries. It is characterised by unexplained fatigue, lasting 6 months or more, impairment of neurocognitive functions and quality of sleep, and of somatic symptoms, such as recurrent sore throat, muscle aches, arthralgias, headache and postexertional malaise. No link between infections and CFS has been clearly established but the immune system is activated, there are aberrations in several hypothalamic-pituitary axes and involvement of other parts of the central nervous system. No specific treatment has been found. Cognitive behavioural therapy is established to be of value to improve quality of life. More effective treatment should result, as advances in biomedical as well as psychological research continue.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12421101     DOI: 10.2165/00003495-200262170-00003

Source DB:  PubMed          Journal:  Drugs        ISSN: 0012-6667            Impact factor:   9.546


  132 in total

1.  Effect of growth hormone treatment in patients with chronic fatigue syndrome: a preliminary study.

Authors:  G Moorkens; H Wynants; R Abs
Journal:  Growth Horm IGF Res       Date:  1998-04       Impact factor: 2.372

Review 2.  Borna disease: a persistent virus infection of the central nervous system.

Authors:  H Ludwig; L Bode; G Gosztonyi
Journal:  Prog Med Virol       Date:  1988

3.  Brain regions involved in fatigue sensation: reduced acetylcarnitine uptake into the brain.

Authors:  Hirohiko Kuratsune; Kouzi Yamaguti; Gudrun Lindh; Birgitta Evengård; Gisela Hagberg; Kiyoshi Matsumura; Masao Iwase; Hirotaka Onoe; Mamoru Takahashi; Takashi Machii; Yuzuru Kanakura; Teruo Kitani; Bengt Långström; Yasuyoshi Watanabe
Journal:  Neuroimage       Date:  2002-11       Impact factor: 6.556

4.  Frequent HHV-6 reactivation in multiple sclerosis (MS) and chronic fatigue syndrome (CFS) patients.

Authors:  D V Ablashi; H B Eastman; C B Owen; M M Roman; J Friedman; J B Zabriskie; D L Peterson; G R Pearson; J E Whitman
Journal:  J Clin Virol       Date:  2000-05       Impact factor: 3.168

5.  Adrenal glucocorticoid function in acute viral infections in children.

Authors:  M M Zeitoun; A I Hassan; Z M Hussein; M S Fahmy; M Ragab; M Hussein
Journal:  Acta Paediatr Scand       Date:  1973-11

6.  Pathophysiology of epidemic St. Louis encephalitis. I. Inappropriate secretion of antidiuretic hormone. II. Pituitary-adrenal function. 3. Cerebral blood flow and metabolism.

Authors:  M G White; N W Carter; F C Rector; D W Seldin; S J Drewry; J P Sanford; J P Luby; R H Unger; N M Kaplan; W Shapiro; S Eisenberg
Journal:  Ann Intern Med       Date:  1969-10       Impact factor: 25.391

Review 7.  Interventions for the treatment and management of chronic fatigue syndrome: a systematic review.

Authors:  P Whiting; A M Bagnall; A J Sowden; J E Cornell; C D Mulrow; G Ramírez
Journal:  JAMA       Date:  2001-09-19       Impact factor: 56.272

8.  Acyclovir treatment of the chronic fatigue syndrome. Lack of efficacy in a placebo-controlled trial.

Authors:  S E Straus; J K Dale; M Tobi; T Lawley; O Preble; R M Blaese; C Hallahan; W Henle
Journal:  N Engl J Med       Date:  1988-12-29       Impact factor: 91.245

9.  Human herpesviruses in chronic fatigue syndrome.

Authors:  H L Wallace; B Natelson; W Gause; J Hay
Journal:  Clin Diagn Lab Immunol       Date:  1999-03

10.  Double-blind placebo-controlled study of the efficacy of oral terfenadine in the treatment of chronic fatigue syndrome.

Authors:  P Steinberg; B E McNutt; P Marshall; C Schenck; N Lurie; A Pheley; P K Peterson
Journal:  J Allergy Clin Immunol       Date:  1996-01       Impact factor: 10.793

View more
  11 in total

Review 1.  Biomarkers for chronic fatigue.

Authors:  Nancy G Klimas; Gordon Broderick; Mary Ann Fletcher
Journal:  Brain Behav Immun       Date:  2012-06-23       Impact factor: 7.217

Review 2.  Fibromyalgia: a rheumatologic diagnosis?

Authors:  Gerhard K M Endresen
Journal:  Rheumatol Int       Date:  2007-07-20       Impact factor: 2.631

3.  Association of chronic fatigue syndrome with human leucocyte antigen class II alleles.

Authors:  J Smith; E L Fritz; J R Kerr; A J Cleare; S Wessely; D L Mattey
Journal:  J Clin Pathol       Date:  2005-08       Impact factor: 3.411

4.  Chiropractic Management of a Patient With Chronic Fatigue: A Case Report.

Authors:  Christopher T Arick
Journal:  J Chiropr Med       Date:  2016-10-18

5.  A pilot study of cognitive behavioral stress management effects on stress, quality of life, and symptoms in persons with chronic fatigue syndrome.

Authors:  Corina Lopez; Michael Antoni; Frank Penedo; Donna Weiss; Stacy Cruess; Mary-Catherine Segotas; Lynn Helder; Scott Siegel; Nancy Klimas; Mary Ann Fletcher
Journal:  J Psychosom Res       Date:  2011-01-15       Impact factor: 3.006

6.  Biomarkers in chronic fatigue syndrome: evaluation of natural killer cell function and dipeptidyl peptidase IV/CD26.

Authors:  Mary A Fletcher; Xiao R Zeng; Kevin Maher; Silvina Levis; Barry Hurwitz; Michael Antoni; Gordon Broderick; Nancy G Klimas
Journal:  PLoS One       Date:  2010-05-25       Impact factor: 3.240

7.  A double-blind, placebo-controlled, randomized, clinical trial of the TLR-3 agonist rintatolimod in severe cases of chronic fatigue syndrome.

Authors:  David R Strayer; William A Carter; Bruce C Stouch; Staci R Stevens; Lucinda Bateman; Paul J Cimoch; Charles W Lapp; Daniel L Peterson; William M Mitchell
Journal:  PLoS One       Date:  2012-03-14       Impact factor: 3.240

8.  Chronic Physical Stress Does Not Interact with Epstein-Barr Virus (EBV)-Encoded Dutpase to Alter the Sickness Response.

Authors:  Taryn G Aubrecht; Zachary M Weil; Bachir Abi Salloum; Maria Eugenia Ariza; Marshall Williams; Brenda Reader; Ronald Glaser; John Sheridan; Randy J Nelson
Journal:  J Behav Brain Sci       Date:  2015-10-27

9.  Plasma cytokines in women with chronic fatigue syndrome.

Authors:  Mary Ann Fletcher; Xiao Rong Zeng; Zachary Barnes; Silvina Levis; Nancy G Klimas
Journal:  J Transl Med       Date:  2009-11-12       Impact factor: 5.531

10.  Effect of supplement with lactic-acid producing bacteria on fatigue and physical activity in patients with chronic fatigue syndrome.

Authors:  Asa Sullivan; Carl E Nord; Birgitta Evengård
Journal:  Nutr J       Date:  2009-01-26       Impact factor: 3.271

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.